Related Experiment Videos
APAP, a sequence-pattern recognition approach identifies substance P as a potential apoptotic peptide.
G del Rio1, S Castro-Obregon, R Rao
1Buck Institute for Age Research, 8001 Redwood Blvd., Novato, CA 94945-1400, USA.
FEBS Letters
|April 20, 2001
Summary
Researchers developed a computational method to identify pro-apoptotic peptides (PAPs) for cancer chemotherapy. This approach aids in discovering new peptide drugs that induce apoptosis in targeted cancer cells.
Area of Science:
- Biochemistry
- Computational Biology
- Oncology
Background:
- Novel cancer chemotherapeutic strategies are needed.
- Pro-apoptotic peptides (PAPs) offer a targeted approach to induce cancer cell death.
- Existing methods for identifying PAPs are limited.
Purpose of the Study:
- To develop a computational method for identifying potential pro-apoptotic peptides.
- To improve the efficacy of peptide-based cancer chemotherapy.
Main Methods:
- Developed the Approach for Predicting Potential Apoptotic Peptides (APAP) computational tool.
- APAP predicts peptide helical content, hydrophobic moment, and isoelectric point.
- Experimentally validated identified peptides, including substance P.
Main Results:
- APAP successfully identified short PAPs.
- Substance P was identified as a PAP and experimentally confirmed as pro-apoptotic.
- Identified PAPs demonstrated toxicity against bacteria and mitochondria, but not extracellular mammalian cells.
Conclusions:
- The APAP computational method is effective for detecting and improving pro-apoptotic peptides.
- This approach has the potential to advance peptide-based cancer chemotherapy.
- Further research can optimize PAPs for targeted cancer treatment.